We are live on ! Find out more
CM

Castleark Management Portfolio holdings

AUM $3.02B
1-Year Est. Return 53.92%
This Fund
S&P 500
This Quarter Est. Return
+26.27%
1 Year Est. Return
+53.92%
3 Year Est. Return
+208.37%
5 Year Est. Return
+342.22%
10 Year Est. Return
+3,246.09%
AUM
$2.67B
AUM Growth
+$119M
Cap. Flow
-$339M
Cap. Flow %
-12.7%
Top 10 Hldgs %
26.02%
Holding
382
New
39
Increased
53
Reduced
139
Closed
54

Top Buys

Rank Stock Value
1
IWN icon
iShares Russell 2000 Value ETF
IWN
+$19.7M
2
NKE icon
Nike
NKE
+$17.4M
3
XLF icon
State Street Financial Select Sector SPDR ETF
XLF
+$15M
4
VCYT icon
Veracyte
VCYT
+$11.7M
5
LRCX icon
Lam Research
LRCX
+$8.72M

Top Sells

Rank Stock Value
1
GLD icon
SPDR Gold Trust
GLD
+$46.2M
2
AAPL icon
Apple
AAPL
+$22M
3
UNH icon
UnitedHealth
UNH
+$18.6M
4
ENPH icon
Enphase Energy
ENPH
+$16.1M
5
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$15.9M

Sector Composition

Rank Sector Weight
1 Technology 30.21%
2 Healthcare 16.44%
3 Consumer Discretionary 16.08%
4 Financials 8.79%
5 Industrials 8.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTAS icon
301
Cintas
CTAS
$86.6B
$262K 0.01%
2,960
– –
FDX icon
302
FedEx
FDX
$73B
$260K 0.01%
1,000
– –
SGEN
303
DELISTED
Seagen Inc. Common Stock
SGEN
$256K 0.01%
+1,460
New +$272K
PFE icon
304
Pfizer
PFE
$143B
$239K 0.01%
6,500
-351
-5% -$12.9K
FISV
305
Fiserv Inc
FISV
$29.7B
$228K 0.01%
2,000
-580
-22% -$62.5K
BP icon
306
BP
BP
$112B
$226K 0.01%
10,997
– –
INCY icon
307
Incyte
INCY
$25.4B
$222K 0.01%
2,550
– –
BMRN icon
308
BioMarin Pharmaceuticals
BMRN
$11.9B
$196K 0.01%
2,240
– –
VRTX icon
309
Vertex Pharmaceuticals
VRTX
$123B
$173K 0.01%
730
-200
-22% -$45.9K
FAST icon
310
Fastenal
FAST
$54.8B
$169K 0.01%
6,920
– –
ITW icon
311
Illinois Tool Works
ITW
$84.1B
$157K 0.01%
770
– –
TRMB icon
312
Trimble
TRMB
$13.6B
$144K 0.01%
2,160
– –
IWO icon
313
iShares Russell 2000 Growth ETF
IWO
$14.1B
$143K 0.01%
500
– –
CEO
314
DELISTED
CNOOC Limited
CEO
$115K ﹤0.01%
1,260
– –
VAR
315
DELISTED
Varian Medical Systems, Inc.
VAR
$114K ﹤0.01%
650
– –
INTC icon
316
Intel
INTC
$413B
$110K ﹤0.01%
2,200
– –
GOOGL icon
317
Alphabet (Google) Class A
GOOGL
$4.12T
$88K ﹤0.01%
1,000
– –
SYK icon
318
Stryker
SYK
$135B
$83K ﹤0.01%
340
– –
LUV icon
319
Southwest Airlines
LUV
$21.7B
$73K ﹤0.01%
1,560
– –
RDS.A
320
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$72K ﹤0.01%
2,040
– –
MOG.A icon
321
Moog Inc Class A
MOG.A
$12.4B
$68K ﹤0.01%
860
– –
MDT icon
322
Medtronic
MDT
$112B
$56K ﹤0.01%
480
– –
RPM icon
323
RPM International
RPM
$13.8B
$53K ﹤0.01%
580
-30,645
-98% -$2.7M
PRAA icon
324
PRA Group
PRAA
$672M
$46K ﹤0.01%
1,150
– –
PAYX icon
325
Paychex
PAYX
$43.4B
$34K ﹤0.01%
360
– –
11 12
13
14 15

Similar funds

MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
JIC
Joel Isaacson & Co New York $3.02B AUM 21.81% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
TAM
Trillium Asset Management Boston, Massachusetts $3.01B AUM 19.96% 1-Year Est. Return
KIA
KCM Investment Advisors Greenbrae, California $3.01B AUM 21.97% 1-Year Est. Return
Members Trust
Members Trust Tampa, Florida $3.01B AUM 10.24% 1-Year Est. Return
BGDI
BW Gestao de Investimentos Sao Paulo, Brazil $3.01B AUM 27.43% 1-Year Est. Return

Castleark Management's Q4 2020 Portfolio in Review

As of Q4 2020, Castleark Management held 382 positions worth $2.67B, up 4.7% from $2.55B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Castleark Management withdrew a net $339M in Q4 2020, closing 54 positions and reducing 139 holdings. Its most notable exit was UnitedHealth, an estimated $18.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Castleark Management opened a new position in iShares Russell 2000 Value ETF worth $21.9M.

  • Castleark Management's largest Q4 2020 buy was iShares Russell 2000 Value ETF: 166,560 shares worth $21.9M.
  • Castleark Management added most to Nike in Q4 2020, an estimated $17.4M increase.
  • Castleark Management's biggest Q4 2020 reduction was SPDR Gold Trust, cutting an estimated $46.2M.
  • Castleark Management fully exited UnitedHealth in Q4 2020, selling an estimated $18.6M.
  • Castleark Management's ten largest holdings make up 26% of its $2.67B portfolio in Q4 2020.
  • Castleark Management opened 39 new positions and closed 54 in Q4 2020.
  • Castleark Management's portfolio value rose 4.7% quarter-over-quarter to $2.67B.

Based on Castleark Management's 13F filing for Q4 2020, filed 17 Feb 2021.